Draft guidance on management of rolling reviews for drug submissions: Rolling review process, eligibility
Draft guidance on management of rolling reviews for drug submissions: Rolling review process, eligibility is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2023-09-01. On CanQuery you can follow the original downloads. Files are available in English and French.
Health Canada is offering an option for a rolling review of a new drug submission (NDS) or supplement to a new drug submission (SNDS) that meets specific eligibility conditions. Sponsors nearing the end of clinical development of a drug can apply to Health Canada for rolling review status for a forthcoming drug submission.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-09-01
Data overview
- Formats
- HTML
- File languages
- English, French